IL17A and asthma: Previous studies have found that EV-D68 induces interleukin-17–dependent airway inflammation and hyperresponsiveness, which might explain the response to bronchodilators and steroids in children without underlying asthma seen in our study and in previous EV-D68 outbreaks (36–38).